TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech ...

We recently published a list of Top 10 AI Stocks Trending On Wall Street. In this article, we are going to take a look at where Tempus AI, Inc.

TD Cowen reinitiated coverage on Tempus AI Inc (NASDAQ:TEM) with a Buy rating, increasing the price target to $74 from a previous target. The stock, currently trading at $61.85, has shown remarkable ...

Current price as of Feb 3, 2025 4:00 p.m. Back to Top ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...

Microsoft's close partner and collaborator, OpenAI, might be suggesting that DeepSeek stole its IP and violated its terms of service. But Microsoft still wants ...

Jan. 30, 2025 — Women who go on to develop postpartum depression (PPD) may have characteristic levels of neuroactive steroids, molecules derived from the hormone progesterone, in their blood ...

Jan. 15, 2025 — Research has established a clear link between racial and ethnic disparities in maternal heart health and higher risks of preterm birth, preeclampsia and cardiovascular issues for ...

Babies born prematurely are also at an increased risk of having serious health problems. Researchers at the University of Toronto are sounding the alarm about the high consumption of ultra ...

The health sciences study all aspects of health, disease and healthcare. This field of study aims to develop knowledge, interventions and technology for use in healthcare to improve the treatment ...

The bank had suspended its rating and price target for Tempus during its $600 million acquisition of Ambry Genetics due to TD Securities' involvement in the deal.